Daniel Faber, MD
Interventional Pain Medicine · Provo, UTNPI 1023049418
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,280 of the $3,689 with a category attached, or 61.8%. 27 manufacturers reported payments, led by Vertiflex, Inc. at 45.1% of the total. Reporting peaked in 2019 at $2,742 and has fallen 99.0% since, to $27 in 2024. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.
Across 110 payments — averaging $33.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$2K
- Abbott$395
- Nevro Corp.$269
- Boston Scientific$255
- Medtronic$210
- Biodelivery Sciences International, Inc.$170
- plus $727 from 21 others
What the payments were for
- Travel & lodging$1,40938%
- Food & beverage$2,28062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 9 | $1,663 |
| Abbott | 17 | $395 |
| Nevro Corp. | 10 | $269 |
| Boston Scientific | 9 | $255 |
| Medtronic(2 entities) | 13 | $210 |
| Biodelivery Sciences International, Inc. | 10 | $170 |
| Acacia Pharma Inc | 6 | $119 |
| AbbVie(2 entities) | 5 | $87 |
| Almatica Pharma LLC | 3 | $60 |
| SPR Therapeutics, Inc | 1 | $51 |
| Tersera Therapeutics LLC | 3 | $49 |
| Scilex Pharmaceuticals Inc. | 3 | $37 |
| Alkermes, Inc. | 2 | $35 |
| MDD US Operations, LLC | 2 | $33 |
| Redhill Biopharma Inc. | 2 | $33 |
| Pfizer | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Novartis | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Stimwave Technologies Incorporated | 1 | $20 |
| Stryker | 1 | $18 |
| Amgen | 1 | $13 |
| Si-bone, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Indivior Inc. | 1 | $11 |
| Assertio Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,449
- Lamitrode SCS Leads$214
- SPECTRA WAVEWRITER$124
How this compares
$3,689 in reported general payments places this provider in the 25th percentile of 26 interventional pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Provo
- J Riley StringhamProvo$13K
- Jason NakkenProvo$6K
- Bryan HoelzerVineyard$718K
- Nathan ClementsSaint George$29K
- Rick ObraySt George$23K
- Brian RichardsonLogan$19K
- Alex NelsonMurray$17K
- Steven LarsenSaint George$14K
- Craig DavisWest Jordan$13K
- Geeta NagpalWest Jordan$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.